BioVoice News

BIO-SUPPLIER: Agilent Technologies has announced the opening of its Customer Experience Center (CEC) and office in Mumbai, reinforcing its long-term commitment to India.

More: https://biovoicenews.com/agilent-launches-a-new-customer-experience-center-in-mumbai/

Agilent launches a new customer experience center in Mumbai - BioVoiceNews The Customer Experience Center forms part of Agilent’s global investment in customer facing infrastructure, including Centers of Excellence and experience centers across major innovation hubs worldwid

BIO-PHARMA: Emcure Pharmaceuticals Limited has announced the price revision of its weight management drug Poviztra® (semaglutide injection) across India. The reduced price would be starting at Rs. 3,999/- per month (4 weekly doses).

More details: https://biovoicenews.com/emcure-pharma-reduces-poviztra-starting-dose-price-by-55-at-rs-3999-per-month/

Emcure Pharma reduces Poviztra® starting dose price by 55% at Rs 3,999 per month - BioVoiceNews Poviztra® (0.25 mg) will now be available at Rs. 999/- per week or Rs. 3,999/- per month inclusive of taxes

BIO-TECH: India’s bioeconomy has expanded from $10 billion in 2014 to over $195 billion in 2026 (~5% of GDP) and is projected to reach nearly $300 billion by 2033.

More: https://biovoicenews.com/indias-bioeconomy-set-to-hit-300b-as-patent-cliff-fuels-innovation-demand-endiya-partners/

India's bioeconomy set to hit $300B as patent cliff fuels innovation demand: Endiya Partners - BioVoiceNews The country houses 2,500+ biotech startups, ~100 incubators, 600+ research institutes, and 200+ accredited labs

ELMED Life Sciences Pvt Ltd has successfully raised $2.7 Million (₹25 crore) in Series A funding from AgriSURE Fund, an agri-focused investment fund managed by NABVENTURES, the venture capital arm of NABARD.

More: https://biovoicenews.com/elmed-life-sciences-raises-2-7-million-in-series-a-funding-from-agrisure-fund/

ELMED Life Sciences raises $2.7 Million in Series A funding from AgriSURE Fund - BioVoiceNews This investment will support the company’s next phase of growth, focused on expanding its manufacturing, strengthening R&D, and scaling distribution across key markets